Reference 2018-740

REF:           2018-740

Subject:       Cancer and metastases treatments

 

Request:

1. Within your health trust how many metastatic breast cancer patients are currently [within the past 6 months] being treated, with any therapy, surgery or palliative care.

 

2. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;

  • disodium pamidronate (Aredia)
  • ibandronic acid or ibandronate (Bondronat)
  • sodium clodronate (Bonefos, Clasteon, Loron)
  • zoledronic acid or zoledronate (Zometa)
  • denosumab (Xgeva)

 

3. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated with adjuvant therapy with the following treatments;

  • disodium pamidronate (Aredia)
  • ibandronic acid or ibandronate (Bondronat)
  • sodium clodronate (Bonefos, Clasteon, Loron)
  • zoledronic acid or zoledronate (Zometa)

 

4. Within your health trust how many metastatic lung cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.

 

5. Within your health trust how many lung cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;

  • disodium pamidronate (Aredia)
  • ibandronic acid or ibandronate (Bondronat)
  • sodium clodronate (Bonefos, Clasteon, Loron)
  • zoledronic acid or zoledronate (Zometa)
  • denosumab (Xgeva)

 

6. Within your health trust how many metastatic renal cell cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.

 

7. Within your health trust how many renal cell carcinoma [RCC] patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;

  • disodium pamidronate (Aredia)
  • ibandronic acid or ibandronate (Bondronat)
  • sodium clodronate (Bonefos, Clasteon, Loron)
  • zoledronic acid or zoledronate (Zometa)
  • denosumab (Xgeva)

 

  

Response:

Please find information attached.

2018-740 – FOI Request – Cancer and metastases treatments [119 kb] PDF